Clinical trial

Lung Cancer Diagnosis by Detecting Epigenetic Imprinting Alterations in Bronchoalveolar Lavage

NCT05707585

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2023-01-29

PhaseN/A

Study timeline

Study start (actual)2023-01-29Date precision: day

Registry last updated2023-02-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

Quantitative Chromogenic Imprinted Gene in situ Hybridization (QCIGISH)DIAGNOSTIC_TEST

Sponsors & collaborators

The Second Affiliated Hospital of Dalian Medical Universitylead sponsor

Fudan Universitycollaborator

Zongda Hospital affiliated to Southeast Universitycollaborator

West China Hospitalcollaborator

Henan Provincial People's Hospitalcollaborator

First Hospital of China Medical Universitycollaborator

Shengjing Hospitalcollaborator

The First Affiliated Hospital of Guangzhou Medical Universitycollaborator

Lisen Imprinting Diagnostics, Inc.collaborator

Mapped research locations

ShanghaiChina1 NanjingJiangsu, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05707585 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.